Brought to you by 
Ameritox licenses exclusive rights to Ridge’s MDDScore depression test
08 May 2012
Executive Summary
CNS diagnostics company Ridge Diagnostics Inc. is licensing Ameritox Ltd. (pain medication monitoring devices) exclusive rights to its MDDScore, a blood test to diagnose major depressive disorder (MDD).
Deal Industry
- Biotechnology
- In Vitro Diagnostics
-
In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing
Deal Status
- Final
Deal Type
-
Alliance
- Includes Equity
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Ameritox licenses exclusive rights to Ridge’s MDDScore depression test
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice